This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana and Interwell Health Expand Value-Based Support to Florida
by Zacks Equity Research
HUM and Interwell Health add Florida to their value-based kidney care program in a bid to improve health outcomes.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $166.33 in the latest trading session, marking a -1.01% move from the prior day.
These Hospital Stocks Are Trouncing the S&P 500 This Year
by Bryan Hayes
The Zacks Rank has consistently identified big winners, regardless of which pocket of the market they may reside.
Centene's Health Net Wins Medi-Cal Contract in California
by Zacks Equity Research
CNC's Health Net unit secures a 54-month Medi-Cal dental contract, which, in turn, is likely to boost its Medicaid membership and presence across California.
The Zacks Analyst Blog Highlights AppLovin, Palantir Technologies, Sprouts Farmers Market, Tenet Healthcare and Vistra
by Zacks Equity Research
AppLovin, Palantir Technologies, Sprouts Farmers Market, Tenet Healthcare and Vistra are part of the Zacks top Analyst Blog.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) reachead $168.03 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close.
5 Must-Buy Large-Cap Stocks With Triple-Digit Returns This Year
by Nalak Das
Several stocks have skyrocketed this year. We have narrowed our search to five stocks that have provided triple-digit returns year to date. These are APP, PLTR, SFM, THC, VST.
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
by Zacks Equity Research
SEM's profitability is being impacted by rising costs and expenses.
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
by Zacks Equity Research
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp
by Zacks Equity Research
TDOC's stock benefits from improving web traffic in its BetterHelp platform.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
by Zubia Masood
HCA benefits from expanding insurance coverage, rising demand and improving margins.
Are You Looking for a Top Momentum Pick? Why Tenet Healthcare (THC) is a Great Choice
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Community Health's Arm Northwest Urgent Buys 10 Arizona Facilities
by Zacks Equity Research
CYH expects the acquisition from Carbon Health to be completed in the fourth quarter of 2024.
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $164.62, representing a +1.36% change from its previous close.
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
by Zacks Equity Research
MD remains one of the best-positioned pediatric service providers with favorable valuation to achieve margin improvement.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
3 Momentum Anomaly Stocks to Buy as Markets Soar on Cooling Inflation
by Supriyo Bose
PPC, THC and MTG are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.